|
 |
 |
 |
 |
|
|
|
|
|
|
Basel, 7 October 2005
Roche becomes founding
member of ICRC Corporate Support Group
Novel partnership between
the International Committee of the Red Cross and the business world
Roche
has joined with several other companies in forging a strategic, long-term partnership with the International
Committee of the Red Cross (ICRC). Jakob Kellenberger, President of ICRC, and representatives of the
companies gathered today in Geneva to launch the ICRC Corporate Support Group, ushering in an innovative
new form of partnership with the ICRC. This partnership is committed to supporting the humanitarian
mission of the ICRC.
Under the terms of the partnership, Roche will provide
significant support to the ICRC over a six-year period starting this year. This support will include
cash donations as well as in-kind donations of goods and services. The ICRC will allocate the resources
it receives from Roche to humanitarian programmes in emergency situations or use them for rehabilitation
purposes in the aftermath of conflicts and major disasters. Additionally, the ICRC may use Roche’s donations
for prevention efforts in areas where an emergency appears likely to occur. Roche will consider the
ICRC its primary global partner for channelling resources to support humanitarian efforts in emergency
situations.
About Roche
Headquartered
in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the
fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the
early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range
of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics,
the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2004
sales by the Pharmaceuticals Division totalled 21.7 billion Swiss francs, while the Diagnostics Division
posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has
R&D agreements and strategic alliances with numerous partners, including majority ownership interests
in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at
www.roche.com. Roche has a long history of active community involvement. In addition
to humanitarian projects, Roche promotes research, the professional development of young scientists
and the arts. The company also encourages its employees to get involved in their local communities.
All
trademarks used or mentioned in this release are protected by law.
Further
information
- International Committee of the Red Cross
-
Roche & Sustainable Development |
|
|
|
|
|
|
|
print this page